QA: Prometheus Biosciences Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001718852_2023_Prometheus_Biosciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001718852, Prometheus Biosciences Inc

  xvar xval
0 AssetsCurrent 708,151,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,877,000
3 remainder_Assets 28,745,000
4 LiabilitiesCurrent 22,817,000
5 LiabilitiesNoncurrent 26,321,000
6 remainder_Liabilities 15,667,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 39,739,000
9 ResearchAndDevelopmentExpense 112,848,000
10 remainder_Expenses 0
11 remainder_Revenues 6,809,000
12 remainder_NetIncome 4,026,000
13 remainder_ComprehensiveNetIncome -429,000
  yvar yval
0 Assets 740,773,000
1 Liabilities 64,805,000
2 Expenses 152,587,000
3 Revenues 6,809,000
4 StockholdersEquity 675,968,000
5 NetIncome -141,752,000
6 ComprehensiveNetIncome -141,966,500
7 BaseVar 484,714,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.31
9 EconomicCapitalRatio 3.89

Edgar->Model Mapping

Feature Distribution